Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycerol phenylbutyrate in children with MCT8 mutation (Allan-Herndon-Dudley syndrome)
MOH_2019-11-17_007491Phase 4Not yet recruiting
- Sponsor
- פרופ. אמנון צונג
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sodium phenylbutyrate in Allan-Herndon-Dudley syndrome (AHDS), sponsored by פרופ. אמנון צונג. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
sodium phenylbutyrate
03
Conditions
Allan-Herndon-Dudley syndrome (AHDS)
Beyond the preview
Go deeper on MOH_2019-11-17_007491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-11-17_007491.